Cargando...
Damoctocog Alfa Pegol: A Review in Haemophilia A
Damoctocog alfa pegol (Jivi(®)) is approved in the USA, EU, Japan and Canada for the treatment and prophylaxis of previously treated patients aged ≥ 12 years with haemophilia A. Formulated with a 60 kDa polyethylene glycol (PEG) moiety, damoctocog alfa pegol is an intravenously (IV) administered rec...
Gardado en:
| Publicado en: | Drugs |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Springer International Publishing
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6711950/ https://ncbi.nlm.nih.gov/pubmed/31218660 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40265-019-01152-7 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|